MiR-1290 targets CCNG2 to promote the metastasis of oral squamous cell carcinoma.
CONCLUSIONS: MiR-1290 promoted cell metastasis and EMT, inhibiting CCNG2 expression in OSCC.
PMID: 31841213 [PubMed - in process]
Source: European Review for Medical and Pharmacological Sciences - Category: Drugs & Pharmacology Tags: Eur Rev Med Pharmacol Sci Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Drugs & Pharmacology | Epithelial Cancer | Oral Cancer | Skin Cancer | Squamous Cell Carcinoma | Study